What is King Pharmaceuticals's all other lines — year 1?

King Pharmaceuticals (KG) reported all other lines — year 1 of 57% in Q4 2025.

What does all other lines — year 1 mean?

This represents the first year of development or maturity for claims within the 'All other lines' segment. It is used in loss development triangles to analyze the speed and pattern of claim reporting and settlement for the most recent underwriting year.

King Pharmaceuticals KG All other lines — Year 1

Other product segments

International

41.8%—

Commercial Auto Liability

11.9%—

General Liability

5.9%—

European Hospital Liability

3.2%—

Similar metrics at other companies

ACGLMulti-line and other specialty — Year One

31.2%-1.6pp

ACGLMulti-line and other specialty — Year Two

29%-0.2pp

GLREMultiline — Year 1

90.2%-4.2pp

SPNTProperty Other — Year 1

39.1%+3.6pp

ACGLMulti-line and other specialty — Year Three

11%0.0pp

ACGLThird party claims-made business — Year One

4.7%+0.3pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's all other lines — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's all other lines — year 1?: King Pharmaceuticals (KG) reported all other lines — year 1 of 57% in Q4 2025.
What does all other lines — year 1 mean?: This represents the first year of development or maturity for claims within the 'All other lines' segment. It is used in loss development triangles to analyze the speed and pattern of claim reporting and settlement for the most recent underwriting year.